Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Ryuma Tanaka MD

Ryuma Tanaka MD profile photo picture

Assistant Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Hematology and Oncology - Pediatrics
Program: Oncology

Member of the Cancer Center
Member of the Center for Immunology
Member of the Neuroscience Research Center

View Curriculum Vitae

Publications (13)

  • Psychiatric symptoms in children with low-grade glioma and craniopharyngioma: A systematic review. (Sherman SJ, Tanaka R, Qaddoumi I) J Psychiatr Res 2022 Apr;148:240-249 PMID: 35149436 SCOPUS ID: 2-s2.0-85124308206 02/13/2022       5 Citations
  • A case of primary CNS embryonal rhabdomyosarcoma with PAX3-NCOA2 fusion and systematic meta-review. (Tanaka R, Inoue K, Yamada Y, Yoshida M, Shima H, Ito J, Okita H, Miwa T, Kato M, Shimada H) J Neurooncol 2021 Sep;154(2):247-256 PMID: 34398431 SCOPUS ID: 2-s2.0-85112831225 08/17/2021       2 Citations
  • Dual inhibition of BRAF and mTOR in BRAFV600E -mutant pediatric, adolescent, and young adult brain tumors. (Sen S, Tanaka R, Khatua S, Zaky W, Janku F, Penas-Prado M, Weathers SP, Behrang A, Roszik J, Subbiah V) Cold Spring Harb Mol Case Stud 2020 Aug;6(4) PMID: 32843426 PMCID: PMC7476413 SCOPUS ID: 2-s2.0-85089926147 08/28/2020       4 Citations
  • Upfront Therapies and Downstream Effects: Navigating Late Effects in Childhood Cancer Survivors in the Current Era. (Phelan R, Eissa H, Becktell K, Bhatt N, Kudek M, Nuechterlein B, Pommert L, Tanaka R, Baker KS) Curr Oncol Rep 2019 Nov 25;21(12):104 PMID: 31768799 SCOPUS ID: 2-s2.0-85075563534 11/27/2019       4 Citations
  • Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function. (Caruso HG, Tanaka R, Liang J, Ling X, Sabbagh A, Henry VK, Collier TL, Heimberger AB) J Neurooncol 2019 Dec;145(3):429-439 PMID: 31686330 SCOPUS ID: 2-s2.0-85074864973 11/07/2019       21 Citations
  • Immunotherapeutic options for pediatric malignancies. (Tanaka R, Heimberger AB) Current Immunology Reviews 2016;12(2):63-73 08/06/2019    
  • EPT-17 Phase I Study of BRAF Inhibitor (Vemurafenib) in combination with the mTOR inhibitor (Everolimus) in BRAFV600E positive childhood and AYA brain tumors (Tanaka R, Khatua S, Zaky W, Penas-Prado M, Weathers S-P, Subbiah V.) Neuro-Oncology 2016;18(suppl 3):iii27. 08/06/2019    
  • IMMU-17. Reducing the ex vivo manufacturing time of EGFRVIII-specific chimeric antigen receptor (CAR) T cells improves phenotype and demonstrates potent anti-glioma function in vivo. (Tanaka R, Caruso H, Ling X, Heimberger AB.) Neuro-Oncology 2017;19(suppl 6):vi116 08/06/2019    
  • Septal dysembryoplastic neuroepithelial tumor: a comprehensive clinical, imaging, histopathologic, and molecular analysis. (Chiang JCH, Harreld JH, Tanaka R, Li X, Wen J, Zhang C, Boué DR, Rauch TM, Boyd JT, Chen J, Corbo JC, Bouldin TW, Elton SW, Liu LL, Schofield D, Lee SC, Bouffard JP, Georgescu MM, Dossani RH, Aguiar MA, Sances RA, Saad AG, Boop FA, Qaddoumi I, Ellison DW) Neuro Oncol 2019 Jun 10;21(6):800-808 PMID: 30726976 PMCID: PMC6556860 SCOPUS ID: 2-s2.0-85067631331 02/07/2019       28 Citations
  • Predicting outcomes of neonates born to GBS-positive women who received inadequate intrapartum antimicrobial prophylaxis. (Kojima K, Tanaka R, Nakajima K, Kurihara N, Oba MS, Yamashita Y, Ishihara J, Yahagi N) Turk J Pediatr 2014;56(3):238-42 PMID: 25341594 SCOPUS ID: 2-s2.0-85006294879 10/25/2014       3 Citations
  • Hypoglycemia associated with L-asparaginase in acute lymphoblastic leukemia treatment: a case report. (Tanaka R, Osumi T, Miharu M, Ishii T, Hasegawa T, Takahashi T, Shimada H) Exp Hematol Oncol 2012 Apr 19;1(1):8 PMID: 23211036 PMCID: PMC3514085 12/06/2012    
  • Congenital corneal staphyloma as a complication of Kabuki syndrome. (Tanaka R, Takenouchi T, Uchida K, Sato T, Fukushima H, Yoshihashi H, Takahashi T, Tsubota K, Kosaki K) Am J Med Genet A 2012 Aug;158A(8):2000-2 PMID: 22786791 SCOPUS ID: 2-s2.0-84864133223 07/13/2012       12 Citations
  • Imatinib is effective for prevention and improvement of fibrotic fasciitis as a manifestation of chronic GVHD. (Osumi T, Miharu M, Tanaka R, Du W, Takahashi T, Shimada H) Bone Marrow Transplant 2012 Jan;47(1):139-40 PMID: 21339748 SCOPUS ID: 2-s2.0-84855741230 02/23/2011       10 Citations
    • Last update: 03/23/2023